One biotech firm, which is developing a drug to combat both HIV and COVID-19, went nuts this week, while punters again flocked to the lithium bandwagon and companies exploring in the emerging hotspot of Canada. FLASHPOINT - TRANSCRIPT Matt Birney - Thanks Tim Matt Birney - Well biotech firm Biotron went nuts this week to hit 7.2c, up from 3.2, with pending clinical trial results for a drug it says just might be able to cure both HIV and COVID-19. Matt Birney - Never far away,